Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

In this technology bride we outline how Abaqua/Standard and Isight can be combined in a process to optimize the vibro-acoustic characteristics of hearing
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

MassDevice.com +3 | The top 3 medtech stories for April 24, 2015

April 24, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Burr introduces fast-track FDA bill

April 24, 2015 by Brad Perriello

Sen. Richard Burr (R-N.C.) introduces a new bill to create fast-track approvals at the FDA for breakthrough medical devices.

Burr introduces fast-track FDA bill

A new Senate bill introduced yesterday would create a fast-track program at the FDA for breakthrough medical devices

The bill, S. 1077 or " A bill to provide for expedited development of and priority review for breakthrough devices," was sponsored by Sen. Richard Burr (R-N.C.) and co-sponsored by Sens. Orrin Hatch (R-Utah) and Michael Bennet (D-Colo.).

Spectranetics to boost Stellarex spend

April 24, 2015 by Brad Perriello

Spectranetics says it plans to boost its R&D spend on the Stellarex drug-eluting balloon it bought from Covidien.

Spectranetics to boost Stellarex spend

Gynesonics raises $3m for VizAblate fibroid device

April 24, 2015 by Mark Hollmer

Gynesonics pulls in $3 million in a new debt financing that will help fuel further development of its VizAblate fibroid treatment device.

Gynesonics raises $3m for VizAblate fibroid device

California's Gynesonics reported raising $3 million in a new debt offering as it pursues development of its VizAblate fibroid treatment device.

Bard shares tick up on Q1 earnings beat

April 24, 2015 by Brad Perriello

Share prices tick up for C.R. Bard after it reports a 1st-quarter earnings beat.

Bard shares tick up on Q1 earnings beat

C.R. Bard (NYSE:BCR) shares gained today after the medical products giant reported 1st-quarter earnings that topped expectations on Wall Street, despite a poor quarterly comparison for its Lutonix drug-eluting balloon.

Halloran Consulting Group Helps Life Science Companies Develop, Manage, and Adhere to Clinical Study Budgets

April 24, 2015 by MassDevice

Halloran expands clinical finance services and licenses leading industry financial forecasting tool to effectively budget and manage clinical trial budgets.

BOSTON, MA – Halloran Consulting Group, the life science management consulting firm, expands its robust range of clinical finance capabilities with the addition of the industry's leading financial forecasting tool.

Reva Medical extends Fantom stent trial to Europe

April 24, 2015 by Mark Hollmer

Reva Medical begins enrolling patients in Europe for a trial of its Fantom bioresorbable stent.

Reva Medical extends Fantom stent trial to Europe